Safety question
Is Apigenin safe?
Yes — within typical dose ranges, by published evidence. Apigenin scores 5/5 on our safety scale. Documented adverse reactions are minor, dose-related, and reversible on stopping. Healthy adults at standard doses tolerate it well in the clinical literature.
Safety score
5 / 5
Evidence grade
B
Severe reactions on file
0
Pubmed cites
400
Key facts
- typical dose
- 50–100 mg
- dose frequency
- 1 dose
- timing
- 30-60 min before bed
- with food
- optional
- safety score
- 5/5
- evidence grade
- B
- class
- neuroprotective
- PubMed citations
- 400
- legal status (US)
- Over-the-counter
- legal status (UK)
- Over-the-counter
- legal status (EU)
- Over-the-counter
- legal status (AU)
- Over-the-counter
- primary mechanism
- Partial agonist at GABA-A receptors at the benzodiazepine binding site, producing mild anxiolytic and sleep-promoting effects without the dependence profile of pharmaceutical benzodiazepines.
Common side effects
No commonly reported side effects on file for Apigenin at typical doses.
Uncommon side effects
- Mild sedation if dosed in AMmild
Who should not take Apigenin
- Pregnant or breastfeeding individuals — most nootropics have not been adequately studied in pregnancy, and the precautionary principle applies.
- Anyone on a prescription medication that overlaps mechanistically (stimulants, SSRIs, MAOIs, beta-blockers, anticoagulants) — clear interactions with your prescribing clinician before adding Apigenin.
- Anyone with significant cardiovascular, hepatic, renal, or psychiatric disease — established conditions raise the baseline risk for any new compound.
- Minors — almost no nootropics have a paediatric safety record, and developing brains are differently sensitive.
What "safe" means here
Our safety scoring reflects (a) published clinical and observational literature on healthy-adult use at standard supplement doses, (b) the spectrum of adverse-event reports in the medical and supplement-pharmacovigilance record, and (c) the regulatory status across major jurisdictions. It does notreflect long-term outcomes in populations that haven’t been studied, and it does not substitute for clinical judgement applied to your individual situation.
A 5/5 score does not mean “no risk” — it means risk has been quantified as low in healthy adults at usual doses. Idiosyncratic and allergic reactions are possible with virtually any compound, including those we rate highest.
Full mechanism, citations, and dose guidance for Apigenin are on the main reference page — see Apigenin. For the dose-by-dose breakdown, see Apigenin dosage. To check stack interactions, use the interaction checker.
This page is informational. It is not medical advice and does not establish a clinician-patient relationship. Individual risk varies with genetics, medications, pre-existing conditions, and dose. Always consult a qualified clinician before starting a new compound. See our full disclaimer and terms.